FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034164410> ?p ?o ?g. }

• W2034164410 endingPage "74" @default.
• W2034164410 startingPage "65" @default.
• W2034164410 abstract "1. Nitric oxide (NO) participates, at least in part, to the establishment and maintenance of pain after nerve injury. Therefore, drugs that target the NO/cGMP signaling pathway are of interest for the treatment of human neuropathic pain. Various compounds endowed with NO-releasing properties modulate the expression and function of inducible nitric oxide synthase (iNOS), the key enzyme responsible for sustained NO production under pathological conditions including neuropathic pain. 2. With this background, we synthesized a new chemical entity, [1-(aminomethyl)cyclohexane acetic acid 3-(nitroxymethyl)phenyl ester] NCX8001, which has a NO-releasing moiety bound to gabapentin, a drug currently used for the clinical management of neuropathic pain. We examined the pharmacological profile of this drug with respect to its NO-releasing properties in vitro as well as to its efficacy in treating neuropathic pain conditions (allodynia) consequent to experimental sciatic nerve or spinal cord injuries. 3. NCX8001 (1-30 microm) released physiologically relevant concentrations of NO as it induced a concentration-dependent activation of soluble guanylyl cyclase (EC(50)=5.6 microm) and produced consistent vasorelaxant effects in noradrenaline-precontracted rabbit aortic rings (IC(50)=1.4 microm). 4. NCX8001, but not gabapentin, counteracted in a concentration-dependent fashion lipopolysaccharide-induced overexpression and function of iNOS in RAW264.7 macrophages cell line. Furthermore, NCX8001 also inhibited the release of tumor necrosis factor alpha (TNFalpha) from stimulated RAW264.7 cells. 5. NCX8001 (28-280 micromol x kg(-1), i.p.) reduced the allodynic responses of spinal cord injured rats in a dose-dependent fashion while lacking sedative or motor effects. In contrast, gabapentin (170-580 micromol x kg(-1), i.p.) resulted less effective and elicited marked side effects. 6. NCX8001 alleviated the allodynia-like responses of rats to innocuous mechanical or cold stimulation following lesion of the sciatic nerve. This effect was not shared by equimolar doses of gabapentin. 7. Potentially due to the slow releasing kinetics of NO, NCX8001 alleviated pain-like behaviors in two rat models of neuropathic pain in a fashion that is superior to its parent counterpart gabapentin. This new gabapentin derivative, whose mechanism deserves to be explored further, offers new hopes to the treatment of human neuropathic pain." @default.
• W2034164410 created "2016-06-24" @default.
• W2034164410 creator A5007995825 @default.
• W2034164410 creator A5050969311 @default.
• W2034164410 creator A5051728034 @default.
• W2034164410 creator A5055926195 @default.
• W2034164410 creator A5056388603 @default.
• W2034164410 creator A5077892371 @default.
• W2034164410 creator A5087726619 @default.
• W2034164410 date "2004-01-01" @default.
• W2034164410 modified "2023-10-13" @default.
• W2034164410 title "A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury" @default.
• W2034164410 cites W1495431285 @default.
• W2034164410 cites W1678800844 @default.
• W2034164410 cites W1754911638 @default.
• W2034164410 cites W1965948569 @default.
• W2034164410 cites W1976219259 @default.
• W2034164410 cites W1979321136 @default.
• W2034164410 cites W1979981300 @default.
• W2034164410 cites W1982939797 @default.
• W2034164410 cites W1986237413 @default.
• W2034164410 cites W1987139868 @default.
• W2034164410 cites W1996123177 @default.
• W2034164410 cites W1998240591 @default.
• W2034164410 cites W2001982896 @default.
• W2034164410 cites W2002543001 @default.
• W2034164410 cites W2010845171 @default.
• W2034164410 cites W2014670473 @default.
• W2034164410 cites W2015788258 @default.
• W2034164410 cites W2021558039 @default.
• W2034164410 cites W2022325044 @default.
• W2034164410 cites W2028124203 @default.
• W2034164410 cites W2029396512 @default.
• W2034164410 cites W2031791494 @default.
• W2034164410 cites W2032446322 @default.
• W2034164410 cites W2033189033 @default.
• W2034164410 cites W2039982019 @default.
• W2034164410 cites W2042071004 @default.
• W2034164410 cites W2054665953 @default.
• W2034164410 cites W2057983296 @default.
• W2034164410 cites W2060922917 @default.
• W2034164410 cites W2069881405 @default.
• W2034164410 cites W2071568997 @default.
• W2034164410 cites W2072253551 @default.
• W2034164410 cites W2079692119 @default.
• W2034164410 cites W2080072795 @default.
• W2034164410 cites W2081881569 @default.
• W2034164410 cites W2086763393 @default.
• W2034164410 cites W2090553554 @default.
• W2034164410 cites W2093671016 @default.
• W2034164410 cites W2102023851 @default.
• W2034164410 cites W2102368782 @default.
• W2034164410 cites W2109541288 @default.
• W2034164410 cites W2123258170 @default.
• W2034164410 cites W2129967138 @default.
• W2034164410 cites W2151482983 @default.
• W2034164410 cites W2174584773 @default.
• W2034164410 cites W2341768699 @default.
• W2034164410 cites W2343207746 @default.
• W2034164410 cites W2598191243 @default.
• W2034164410 cites W4245950111 @default.
• W2034164410 doi "https://doi.org/10.1038/sj.bjp.0705596" @default.
• W2034164410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1574179" @default.
• W2034164410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14662726" @default.
• W2034164410 hasPublicationYear "2004" @default.
• W2034164410 type Work @default.
• W2034164410 sameAs 2034164410 @default.
• W2034164410 citedByCount "40" @default.
• W2034164410 countsByYear W20341644102012 @default.
• W2034164410 countsByYear W20341644102013 @default.
• W2034164410 countsByYear W20341644102014 @default.
• W2034164410 countsByYear W20341644102016 @default.
• W2034164410 countsByYear W20341644102018 @default.
• W2034164410 countsByYear W20341644102019 @default.
• W2034164410 countsByYear W20341644102020 @default.
• W2034164410 countsByYear W20341644102022 @default.
• W2034164410 countsByYear W20341644102023 @default.
• W2034164410 crossrefType "journal-article" @default.
• W2034164410 hasAuthorship W2034164410A5007995825 @default.
• W2034164410 hasAuthorship W2034164410A5050969311 @default.
• W2034164410 hasAuthorship W2034164410A5051728034 @default.
• W2034164410 hasAuthorship W2034164410A5055926195 @default.
• W2034164410 hasAuthorship W2034164410A5056388603 @default.
• W2034164410 hasAuthorship W2034164410A5077892371 @default.
• W2034164410 hasAuthorship W2034164410A5087726619 @default.
• W2034164410 hasBestOaLocation W20341644102 @default.
• W2034164410 hasConcept C118552586 @default.
• W2034164410 hasConcept C126322002 @default.
• W2034164410 hasConcept C142724271 @default.
• W2034164410 hasConcept C15490471 @default.
• W2034164410 hasConcept C170493617 @default.
• W2034164410 hasConcept C173803235 @default.
• W2034164410 hasConcept C185592680 @default.
• W2034164410 hasConcept C204787440 @default.
• W2034164410 hasConcept C2775991916 @default.
• W2034164410 hasConcept C2776608144 @default.
• W2034164410 hasConcept C2777107010 @default.
• W2034164410 hasConcept C2777622882 @default.

• next